ESA advances ERS program, marking shift toward dual-use and defense
Milan — The European Space Agency has refined its plan for the European Resilience from Space (ERS) program,…
Lilly and Novo Rise on Report of Deal for Medicare Coverage
Shares of Eli Lilly & Co and Novo Nordisk A/S rose on a report that the companies were…
UK Weighs 20% Exit Charge on Wealthy Individuals as Budget Tightens
The UK is considering a 20% tax on certain assets held by individuals who leave the country, signalling…
China slams Netherlands for chip supply snarls tied to Nexperia | Trade War News
A dispute between Amsterdam and Beijing over technology transfer has held up chip supplies to car manufacturers. Published…
Exploring Undiscovered Gems in Europe for November 2025
As European markets navigate a mixed landscape with the pan-European STOXX Europe 600 Index experiencing slight declines and…
Hong Kong Finance Chief Says City Set to Hit Year’s Growth Goal
Hong Kong is poised to achieve its goal for economic growth this year, Financial Secretary Paul Chan wrote…
Egypt Unveils $1 Billion Grand Museum as a ‘Gift to the World’
Egypt inaugurated a long-anticipated $1 billion museum that showcases the wonders of its ancient past and is poised…
How did Chen-ning Yang miss out on a second Nobel Prize in physics?
Since the Nobel Prize began recognising exceptional achievements in science, literature and peace in 1901, only five scientists…
EnduroSat raises $104 million to scale production of larger small satellites
TAMPA, Fla. — Bulgaria’s EnduroSat announced another $104 million in venture capital funding Oct. 30 to scale up…
Underpaid? The highest and lowest ranking sectors for employee pay satisfaction in Europe
Is the average European worker’s dream to become a clerk in the Netherlands? There’s no study to prove…
‘Unforgivable’: Chinese county still living in shadow of wild spending binge
Few areas of China reflect the country’s decades-long economic transformation more vividly than its cities. Rapid development has…
Why an Old Multiple Sclerosis Drug Costs More Than Ever in the US
When Jean Kay started a brand-new multiple sclerosis treatment called Rebif in 2003, it cost $17,500 a year.…